Physician profile
Edwin C Winder
NPI 1457369621
$2,692.64
in general payments reported to CMS, 2019-2025
11 companies · $472 in 2025
The $472 reported for 2025 was more than what 76% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $674 · 2020: $155 · 2021: $440 · 2022: $407 · 2023: $321 · 2024: $223 · 2025: $472.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $974 · Entertainment: $42.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $973.89 |
| Entertainment | $42.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $605.39 | 2019-2021 | |
| Coopervision INC. | $531.65 | 2019-2025 | Myday Contact Lens |
| Alcon Vision LLC | $413.66 | 2021-2025 | Precision7, Total30, Precision 1 |
| Bausch & Lomb Americas INC. | $312.32 | 2022-2025 | Infuse, Biotrue One Day, Biotrue |
| Optos, INC. | $219.32 | 2021-2024 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Carl Zeiss Meditec USA, INC. | $205.85 | 2021-2023 | Forum |
| Johnson & Johnson Vision Care, INC. | $137.71 | 2019-2024 | Acuvue |
| Allergan, INC. | $129.17 | 2019 | |
| Sun Pharmaceutical Industries INC. | $98.64 | 2020 | |
| Johnson & Johnson Surgical Vision, INC. | $21.67 | 2021 | |
| Lombart Brothers, INC. | $17.26 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edwin Winder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.